<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04571918</url>
  </required_header>
  <id_info>
    <org_study_id>2019/930</org_study_id>
    <nct_id>NCT04571918</nct_id>
  </id_info>
  <brief_title>Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and Biodegradable Spacer.</brief_title>
  <acronym>AMRIS</acronym>
  <official_title>Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and or Biodegradable Spacer: a Prospective Randomized Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Massive rotator cuff tears are common in the adult population. It is estimated that about 12&#xD;
      % of adults 60 years of age or older suffer from a rotator cuff injury. About 40 % of these&#xD;
      injuries are classified as massive rotator cuff tears (MRCT). MRCT propose a great challenge&#xD;
      to the affected patient and its doctor. It is a painful condition with few treatment options.&#xD;
&#xD;
      The study aims to investigate the operative treatment for MRCT with the new treatment option&#xD;
      proposed by Senecovic. Insertion of a biodegradable balloon as a subacromial spacer has&#xD;
      proven promising results so far. To this date there is only small and non-randomized studies&#xD;
      on the subject. AMRIS are planning to do a randomized controlled study where group A is&#xD;
      treated with arthroscopic debridement, biceps tenotomy and biodegradable spacer, while group&#xD;
      B, the control group are treated with arthroscopic debridement and biceps tenotomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is designed as a double blinded randomized controlled trial. The physiotherapist&#xD;
      responsible for the clinical testing and the patient are both blinded. The surgeon knows&#xD;
      which group the patient is in but is not responsible for any of the testing. We will&#xD;
      randomize with envelopes perioperatively. The participants are randomized in hence &quot;ballon&quot;&#xD;
      or &quot;not ballon&quot;. In advance of the randomization the surgeon will evaluate if the patient is&#xD;
      candidate for partial suture before randomization. We plan to stratify the patients with&#xD;
      partial suture to ensure homogeneity between the groups.&#xD;
&#xD;
      The operation will start with arthroscopic debridement and biceps tenotomy in both groups.&#xD;
      The patients are thereby evaluated for partial suture and randomized. The insertion of the&#xD;
      subacromial spacer is done at the end of the operation for those patients randomized to the&#xD;
      group &quot;balloon&quot;. Peroperatively the surgeon will classify the grade of osteoarthritis with&#xD;
      Outerbridge classification and the state of the rotator cuff and the long head of the biceps&#xD;
      tendon.&#xD;
&#xD;
      Postoperative mobilization will be the following:&#xD;
&#xD;
        -  0-2 weeks: Immobilization in a sling. The participant is advised to do simple exercises&#xD;
           for shoulder mobilization. Restriction of movement above shoulder level.&#xD;
&#xD;
        -  2-6 weeks: Free mobilization. Advised to avoid heavy lifting.&#xD;
&#xD;
        -  6-12 weeks: Work on increasing range of motion, gradually introduce weight lifting.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2029</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Both participant and physiotherapist who are responsible for the testing will be masked.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Constant score</measure>
    <time_frame>Preop, 6 months, 1 year, 2 years, 5 years, 10 years.</time_frame>
    <description>A well review score that takes several factors in to account: active range of motion, activities of daily living, pain and strength. A person with a normal, healthy shoulder should score 100 points, which is maximum score. Constant score is seen as a relatively objective test, as the testing will be performed by a physiotherapist.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>WORC</measure>
    <time_frame>Preop. Postop: 3 months, 6 months, 1 year, 2 years, 5 years, 10 years</time_frame>
    <description>Western Ontario Rotator Cuff Index is a questionnaire that explores 5 domains: physical symptoms, sports and recreation, work, social function, emotions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>X-ray of the shoulder</measure>
    <time_frame>Preop. Postop: 1. day, 1 year, 2 years, 5 years, 10 years</time_frame>
    <description>Measure the height from the head of the humerus to the acromion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS</measure>
    <time_frame>Preop. Postop: 3 months, 6 months, 1 year, 2 years, 5 years, 10 years</time_frame>
    <description>Visual analog scale for pain in rest, activity and at night. Scale from 0 til 10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Eq-5D</measure>
    <time_frame>Preop. Postop: 3 months, 6 months, 1 year, 2 years, 5 years, 10 years</time_frame>
    <description>Questionaire for daily activity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Massive Rotator Cuff Tears</condition>
  <arm_group>
    <arm_group_label>Group A: Biodegradable spacer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B: control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biodegradable spacer</intervention_name>
    <description>Implantation of a biodegradable balloon used as a subacromial spacer.</description>
    <arm_group_label>Group A: Biodegradable spacer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Debridement and biceps tenotomy</intervention_name>
    <description>Surgery with arthroscopic debridement and biceps tenotomy</description>
    <arm_group_label>Group A: Biodegradable spacer</arm_group_label>
    <arm_group_label>Group B: control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients suffering from a symptomatic massive rotator cuff tear, with fatty&#xD;
             infiltration grade 3 or 4 classified on CT by Goutallier et al, or MRI by Fuchs&#xD;
             classification.&#xD;
&#xD;
          -  Persistent pain for at least 3 months, with documented failure of conservative&#xD;
             treatment&#xD;
&#xD;
          -  Age ranging from 60 years of age to 85 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant shoulder osteoarthritis in the affected shoulder, Hamada classification&#xD;
             &gt;2.&#xD;
&#xD;
          -  Total rupture of subscapularis tendon and/or teres minor, classified B and E in the&#xD;
             Collins classification.&#xD;
&#xD;
          -  Comorbidity to the degree that the patient will not be able to participate in the&#xD;
             follow up program.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hannah Ugletveit Jahr, Cand. med</last_name>
    <role>Study Director</role>
    <affiliation>Hospital of southern Norway</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hannah Ugletveit Jahr, Cand. med.</last_name>
    <phone>+47 90762377</phone>
    <email>hannah.jahr@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Berte BÃ¸e, PhD</last_name>
    <phone>+47 41338451</phone>
    <email>uxbebm@ous-hf.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital of Southern Norway, Arendal</name>
      <address>
        <city>Arendal</city>
        <zip>4848</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hannah U. Jahr, Cand.med</last_name>
      <phone>+4790762377</phone>
      <email>hannahuj@sshf.no</email>
    </contact>
    <contact_backup>
      <last_name>Marek W Zegzdryn, cand.med</last_name>
      <phone>+4791143329</phone>
      <email>marek.walerian.zegzdryn@sshf.no</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Oslo university hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Berte BÃ¸e, PhD</last_name>
      <phone>+4741338451</phone>
      <email>uxbebm@ous-hf.no</email>
    </contact>
    <contact_backup>
      <last_name>Ragnhild StÃ¸en, PhD</last_name>
      <email>stox@ous.hf.no</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>June 29, 2020</study_first_submitted>
  <study_first_submitted_qc>September 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2020</study_first_posted>
  <last_update_submitted>September 25, 2020</last_update_submitted>
  <last_update_submitted_qc>September 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Hannah U. Jahr</investigator_full_name>
    <investigator_title>Resident in Orthopedic surgery</investigator_title>
  </responsible_party>
  <keyword>Ballon spacer</keyword>
  <keyword>Biodegradable spacer</keyword>
  <keyword>Subacromial spacer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rotator Cuff Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>To ensure anonymization of participants, there is no plan to share individual data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

